يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Malalties congènites - Tractament"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Baum MA Division of Nephrology, Boston Children’s Hospital, Boston, Massachusetts, USA. Langman C Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Cochat P Reference Centre for Rare Renal Diseases, Hôpital Femme Mère Enfant, Lyon, France. Lieske JC Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA. Moochhala SH UCL Department of Renal Medicine, Royal Free Hospital, London, UK. Hamamoto S Department of Nephro-urology, Nagoya City University, Nagoya, Japan. Ariceta G Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Kidney International;103(1); https://doi.org/10.1016/j.kint.2022.07.025Test; Baum MA, Langman C, Cochat P, Lieske JC, Moochhala SH, Hamamoto S, et al. PHYOX2: A Pivotal Randomized Study of Nedosiran in Primary Hyperoxaluria Type 1 or 2. Kidney Int. 2023 Jan;103(1):207-17.; https://hdl.handle.net/11351/8992Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ariceta G Vall d’Hebron Hospital Universitari, Barcelona, Spain. Collard L Centre Hospitalier Umniversitaire de Liege, Liege, Belgium. Abroug S Hôpital Universitaire Sahloul, Sousse, Tunisia. Moochhala SH Royal Free Hospital, London, UK. Gould E Vanderbilt University Hospital, Nashville, USA. Boussetta A Charles Nicolle University Hospital, Tunis, Tunisia. Fraga G Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hospital Sant Pau, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Pediatric Nephrology;38(2); https://doi.org/10.1007/s00467-022-05591-5Test; Ariceta G, Collard L, Abroug S, Moochhala SH, Gould E, Boussetta A, et al. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. Pediatr Nephrol. 2023 Feb;38(2):403–15.; https://hdl.handle.net/11351/8962Test; 000794091100003

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Carcavilla A Pediatric Endocrinology Department, Hospital Universitario La Paz, Madrid, Spain. Multidisciplinary Unit for RASopathies, Hospital Universitario La Paz, Madrid, Spain. Cambra A, Santomé JL Molecular Diagnostics Laboratory, Department of Laboratory Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Gregorio Marañon Health Research Institute (IiSGM), Madrid, Spain. Seidel V Clinical Genetics Unit, Pediatrics Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Cruz J Pediatrics Department, Hospital Universitario Doce de Octubre, Madrid, Spain. Alonso M Pediatrics Department, Hospital Ramón y Cajal, Madrid, Spain. Valenzuela I Àrea de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal of Clinical Medicine;12(15); https://doi.org/10.3390/jcm12155003Test; Carcavilla A, Cambra A, Santomé JL, Seidel V, Cruz J, Alonso M, et al. Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. J Clin Med. 2023 Jul 29;12(15):5003.; https://hdl.handle.net/11351/10172Test; 001046261200001

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Israni M, Nicholson B Department of Immunology, Royal Free London NHS Foundation Trust, London, UK. Mahlaoui N Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. rench National Reference Center for Primary Immune Defciencies (CEREDIH), Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Obici L Fondazione IRCCS Policlinico San Matteo, Centro Per Lo Studio E La Cura Delle Amiloidosi Sistemiche, Pavia, Italy. Rossi-Semerano L Department of Pediatric Rheumatology, National Reference Centre for Auto-Infammatory Diseases and Amyloidosis of Infammatory Origin (CEREMAIA), Bicêtre hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, France. Lachmann H Division of Medicine, National Amyloidosis Centre, University College London, London, UK. Soler-Palacin P Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Jefrey Modell Diagnostic and Research Center for Primary Immunodefciencies, Barcelona, Catalonia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal of Clinical Immunology;43; https://doi.org/10.1007/s10875-022-01345-yTest; Israni M, Nicholson B, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H, et al. Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey. J Clin Immunol. 2023 Jan;43:206–16.; https://hdl.handle.net/11351/8963Test; 000866293200001

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Martín-Hernández E, Quijada-Fraile P Centro de Referencia Nacional (CSUR) y Europeo (MetabERN) en Enfermedades Metabólicas, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, CIBERER, Madrid, Spain. Correcher P Centro de Referencia Nacional de Enfermedades Metabólicas (CSUR), Hospital La Fe de Valencia, Valencia, Spain. Meavilla S Centro de Referencia Nacional (CSUR) y Europeo (MetabERN) de Enfermedades Metabólicas, Hospital San Joan de Deu Barcelona, Esplugues de Llobregat, Spain. Sánchez-Pintos P Centro de Referencia Nacional (CSUR) y Europeo (MetabERN) de Enfermedades Metabólicas, Hospital Clínico Universitario de Santiago de Compostela, IDIS, CIBERER, Santiago de Compostela, Spain. de Las Heras Montero J Division of Pediatric Metabolism, CIBERER, MetabERN, Cruces University Hospital, University of the Basque Country (UPV/EHU) and Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain. Dougherty L, Camprodon Gómez M, Del Toro M Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal of Clinical Medicine;11(17); https://doi.org/10.3390/jcm11175045Test; Martín-Hernández E, Quijada-Fraile P, Correcher P, Meavilla S, Sánchez-Pintos P, de Las Heras Montero J, et al. Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain. J Clin Med. 2022 Aug 28;11(17):5045.; https://hdl.handle.net/11351/8447Test; 000851177100001

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Nowotny H Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany. Neumann U Centre for Chronic Sick Children, Department of Paediatric Endocrinology and Diabetology, Charité Universitätsmedizin Berlin, Berlin, Germany. Tardy-Guidollet V Laboratoire de Biochimie et Biologie Moléculaire, Hospices Civils de Lyon, Centre National de Référence ‘Développement Génital: du fœtus à l’adulte DEV-GEN’ Université Lyon I, Lyon, France. Ahmed SF Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK. Baronio F Paediatric Endocrinology Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, Bologna, Italy. Battelino T Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, University Children’s Hospital, Ljubljana, Slovenia. Yeste D Servei d’Endocrinologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERER, ISCIII, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: European Journal of Endocrinology;186(5); https://doi.org/10.1530/EJE-21-0554Test; Nowotny H, Neumann U, Tardy-Guidollet V, Ahmed SF, Baronio F, Battelino T, et al. Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe. Eur J Endocrinol. 2022 Mar 23;186(5):K17–K24.; https://hdl.handle.net/11351/7889Test; 000802046600004

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Pitcher A The Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Spata E, Emberson J, Davies K, Halls H, Holland L MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Evangelista A Servei de Cardiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. European Reference Network for Rare Multisystemic Vascular Disease (VASCERN), HTAD Rare Disease Working Group, Barcelona, Spain. Teixido-Turà G Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER-CV, Vall d’Hebron institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. European Reference Network for Rare Multisystemic Vascular Disease (VASCERN), HTAD Rare Disease Working Group, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: The Lancet;400(10355); https://doi.org/10.1016/S0140-6736Test(22)01534-3; Pitcher A, Spata E, Emberson J, Davies K, Halls H, Holland L, et al. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. Lancet. 2022 Sep 10;400(10355):822–31.; https://hdl.handle.net/11351/8425Test

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Serapiglia V School of Medicine, Northeast Ohio College of Medicine, Northeast Ohio Medical University, Rootstown Township, OH, United States. Stephens CA Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States. Joshi R Division of Critical Care Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Aydin E Department of Pediatric Surgery, Tekirdag Namik Kemal University School of Medicine, Tekirdag, Turkey. Center for Fetal and Placental Research, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, United States. Oria M, Peiro JL Center for Fetal and Placental Research, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, OH, United States. Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, United States. Marotta M Laboratori de Bioenginyeria, Teràpia Cel•lular i Cirurgia en Malformacions Congènites, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Varisco BM Division of Critical Care Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, United States, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Pediatrics;9; https://doi.org/10.3389/fped.2021.780166Test; Serapiglia V, Stephens CA, Joshi R, Aydin E, Oria M, Marotta M, et al. Fetal Tracheal Occlusion Increases Lung Basal Cells via Increased Yap Signaling. Front Pediatr. 2022 Feb 22;9:780166.; https://hdl.handle.net/11351/7921Test; 000769802800001

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Lawrence N Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK. Bacila I Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. Dawson J Institute of Work Psychology, Management School, University of Sheffield, Sheffield, UK. School of Health and Related Research, University of Sheffield, Sheffield, UK. Bryce J Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK. Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK. Ali SR Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK. Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK. Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK. van den Akker ELT Department of Pediatric Endocrinology, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, the Netherlands. Clemente M Servei d’Endocrinologia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. CIBER de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Endocrinology;97(5); https://doi.org/10.1111/cen.14796Test; Lawrence N, Bacila I, Dawson J, Bryce J, Ali SR, van den Akker ELT, et al. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry. Clin Endocrinol. 2022 Nov;97(5):551–61.; https://hdl.handle.net/11351/8493Test; 000822943200001

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Guilarte M, Sala-Cunill A Secció d’Al•lèrgia, Servei de Medicina, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Research Network on Allergy (National Allergy Network ARADyAL: Asma, Reacciones Adversas y Alérgicas), Instituto de Salud Carlos III, Madrid, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Baeza ML Allergy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Biomedical Research Network on Rare Diseases, CIBERER-U761, Gregorio Marañón Health Research Institute, Madrid, Spain. Cabañas R Allergy Department, Hospital Universitario La Paz, Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain. Biomedical Research Network on Rare Diseases, CIBERER-U754, Madrid, Spain. Hernández MD, Ibañez E Allergy Department, IIS-Hospital Universitari I Politècnic La Fe, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Allergy, Asthma & Clinical Immunology;17; https://doi.org/10.1186/s13223-021-00641-3Test; Guilarte M, Sala-Cunill A, Baeza ML, Cabañas R, Hernández MD, Ibañez E, et al. Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain. Allergy, Asthma Clin Immunol. 2021 Dec 29;17:137.; https://hdl.handle.net/11351/7700Test; 000736714300001